Pflugerville, TX, United States of America

Feng Zhang

USPTO Granted Patents = 42 

 

Average Co-Inventor Count = 2.5

ph-index = 12

Forward Citations = 721(Granted Patents)


Location History:

  • Burlingame, CA (US) (2013 - 2016)
  • Austin, TX (US) (2002 - 2018)
  • West Lafayette, IN (US) (2019 - 2020)
  • Pflugerville, TX (US) (2014 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
42 patents (USPTO):Explore Patents

Title: Feng Zhang: Innovator in Therapeutic Compositions for ADHD

Introduction

Feng Zhang, based in Pflugerville, Texas, is an accomplished inventor with a remarkable portfolio of 38 patents to his name. His innovations primarily focus on therapeutic compositions aimed at treating attention deficit hyperactivity disorder (ADHD). Zhang's work in this field showcases his dedication to improving the quality of life for those affected by ADHD through innovative formulations.

Latest Patents

Among his latest patents, Feng Zhang has developed compositions that deliver therapeutic amounts of methylphenidate, an essential medication for ADHD. These therapeutic compositions are designed in a unique delayed and extended release formulation, which exhibits a lag time prior to the release of the active ingredient ranging from 6 to 8 hours or longer. Following this initial lag, a sustained release period ensures that the medication remains effective over an extended time frame. This innovative approach represents a significant advancement in the management of ADHD.

Career Highlights

Zhang's career is marked by his association with prominent companies such as Ironshore Pharmaceuticals & Development, Inc. and Auxilium US Holdings, LLC. His experience in these organizations has positioned him as a leading figure in pharmaceutical innovation, particularly in developing new treatment methodologies for ADHD.

Collaborations

Throughout his career, Feng Zhang has collaborated with notable professionals, including David Lickrish and John Joseph Koleng, Jr. These partnerships have contributed to his success and have fostered the development of groundbreaking therapeutic solutions aimed at enhancing patient care.

Conclusion

Feng Zhang's contributions to the field of ADHD treatment through his numerous patents illustrate his commitment to innovation in pharmaceuticals. With a focus on creating effective therapeutic compositions, he continues to be a pivotal figure in advancing treatment options for ADHD. His work not only impacts the medical community but also offers hope to countless individuals seeking relief from this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…